Author:
Lertjanyakun Verin,Chaiyakunapruk Nathorn,Kunisawa Susumu,Imanaka Yuichi
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference56 articles.
1. Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.
2. Cancer statistics in Japan’16. Foundation for Promotion of Cancer Research (FPCR); 2016.
3. Cancer statistics in Japan’15. Foundation for Promotion of Cancer Research (FPCR); 2015.
4. Kourlaba G, Rapti V, Alexopoulos A, et al. Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study. BMC Health Serv Res. 2015;15:307.
5. Yamashita H, Iwase H, Toyama T, et al. Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. Ann Oncol. 2011;22(6):1318–25.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献